High-Throughput Screening Strategies for the Development of Anti-Virulence Inhibitors Against Staphylococcus aureus

被引:16
|
作者
Cai, Xiaodan [1 ]
Zheng, Weihao [1 ]
Li, Zigang [1 ]
机构
[1] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Shenzhen 518055, Guangdong, Peoples R China
关键词
High-throughput screening; anti-virulence; Staphylococcus aureus; agr; SarA/MgrA; sortase A; ClpP; Stp1; SER/THR PROTEIN-KINASES; GLOBAL REGULATOR MGRA; SERINE/THREONINE KINASE; SURFACE-PROTEINS; SORTASE; PHOSPHATASE; CLPP; PHOSPHORYLATION; IDENTIFICATION; EXPRESSION;
D O I
10.2174/0929867324666171121102829
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The increasing threats of antibiotic resistance urge the need for developing new approaches to combat bacterial infections including those caused by Staphylococcus aureus (S. aureus). Unlike conventional antibiotics that aim to kill bacteria or inhibit their growth, targeting bacterial virulence may be a promising alternative approach, which imposes less selective pressure for antibiotic resistance in future generations. Objective: Our goal is to provide a systematic review about developing high-throughput screening (HTS) strategies for the identification of inhibitors targeting virulence of S. aureus. We also describe an overview of virulence regulatory pathways for potential anti-virulence targets. Methods: We focus on five potential targets or target families, including agr quorum sensing system, SarA/MgrA protein family, sortase A, Clp protease and eukaryotic-like Ser/Thr phosphatase (Stp1). For each target, we introduce its role in virulence regulation, summarize the HTS approaches that are used to identify novel anti-virulence inhibitors, and discuss the advantages and disadvantages of these strategies. Conclusion: The discovery of anti-virulence inhibitors via HTS underlines the promising potential of anti-virulence therapy for S. aureus. The development of HTS strategies can facilitate the identification of novel anti-virulence inhibitors for combating S. aureus infection, and may also advance our understanding on virulence regulation in S. aureus.
引用
收藏
页码:2297 / 2312
页数:16
相关论文
共 50 条
  • [1] Chitooligosaccharides as Antibacterial, Antibiofilm, Antihemolytic and Anti-Virulence Agent against Staphylococcus aureus
    Khan, Fazlurrahman
    Lee, Jang-Won
    Pham, Dung T. N.
    Kim, Young-Mog
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2019, 20 (14) : 1223 - 1233
  • [2] Dehydrosqualene Desaturase as a Novel Target for Anti-Virulence Therapy against Staphylococcus aureus
    Gao, Peng
    Davies, Julian
    Kao, Richard Yi Tsun
    MBIO, 2017, 8 (05):
  • [3] Revisiting the Staphylococcus aureus SarA regulon by high-throughput screening
    Oriol, C.
    Cengher, L.
    Manna, A.
    Mauro, T.
    Pinel-Marie, M.
    Rouillon, A.
    Cheung, A.
    Felden, B.
    FEBS OPEN BIO, 2021, 11 : 112 - 112
  • [4] High-throughput screening and Bayesian machine learning for copper-dependent inhibitors of Staphylococcus aureus
    Dalecki, Alex G.
    Zorn, Kimberley M.
    Clark, Alex M.
    Ekins, Sean
    Narmore, Whitney T.
    Tower, Nichole
    Rasmussen, Lynn
    Bostwick, Robert
    Kutsch, Olaf
    Wolschendorf, Frank
    METALLOMICS, 2019, 11 (03) : 696 - 706
  • [5] Anti-virulence potential of patuletin, a natural flavone, against Staphylococcus aureus: In vitro and In silico investigations
    Metwaly, Ahmed M.
    Saleh, Moustafa M.
    Alsfouk, Bshra A.
    Ibrahim, Ibrahim M.
    Abd-Elraouf, Muhamad
    Elkaeed, Eslam B.
    Eissa, Ibrahim H.
    HELIYON, 2024, 10 (02)
  • [6] Carthamus tinctorius L., as an Anti-virulence Intervention Against Methicillin Resistance Staphylococcus aureus
    Abdulhaq, Ahmed A.
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2022, 18 (06) : 1219 - 1228
  • [7] Anti-Virulence and Cytotoxic Behavior of Copper Nanoparticles against antibiotics-resistant Staphylococcus aureus
    El-Waseif, Amr A.
    Eissa, Hind A.
    El Maaty, Sabah A. Abo
    Hassan, Mervat G.
    EGYPTIAN JOURNAL OF CHEMISTRY, 2022, 65 (09): : 361 - 367
  • [8] Anti-virulence potential of iclaprim, a novel folic acid synthesis inhibitor, against Staphylococcus aureus
    Hao, Lingyun
    Zhou, Jingwen
    Yang, Han
    He, Chunyan
    Shu, Wen
    Song, Haoyue
    Liu, Qingzhong
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2024, 108 (01)
  • [9] Anti-virulence compounds against Staphylococcus aureus associated with bovine mastitis: A new therapeutic option?
    Sabino, Yasmin Neves Vieira
    Cotter, Paul David
    Mantovani, Hilario C.
    MICROBIOLOGICAL RESEARCH, 2023, 271
  • [10] Targeting Staphylococcus aureus Toxins: A Potential form of Anti-Virulence Therapy
    Kong, Cin
    Neoh, Hui-min
    Nathan, Sheila
    TOXINS, 2016, 8 (03):